Crowell & Moring LLP
Cancer therapy with a parvovirus combined with an HDAC inhibitor
Described is a pharmaceutical composition comprising (a) a parvovirus and (b) a histone deacetylase inhibitor (HDACI) and the use of said composition for treatment of cancer, e.g., brain tumor, cervical carcinoma, or pancreatic carcinoma.
Deutsches Krebsforschungszentrum
A C A A A A A A
A61K C12N A61P A61K A61K A61K A61P A61K
inventional additional inventional inventional inventional inventional inventional inventional
Junwei Nazim Georgi Antonio Jean
Li El-Andaloussi Hristov Marchini Rommelaere